J. Petrie

发表

Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain

A. Monto, S. Hensley, Tyler A. Garretson, 2018, bioRxiv.

Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.

A. Monto, J. Petrie, S. Ohmit, 2015, The Journal of infectious diseases.

Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015

B. Flannery, E. Belongia, J. Petrie, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011-2012 Through 2014-2015.

B. Flannery, E. Belongia, J. Petrie, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.

T. Braun, M. Eichelberger, A. Monto, 2016, The Journal of infectious diseases.

Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans

A. Monto, S. Hensley, J. Petrie, 2018, Journal of Virology.

Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humans

A. Monto, S. Hensley, J. Petrie, 2018, bioRxiv.

Frequency of Acute Respiratory Illnesses and Circulation of Respiratory Viruses in Households With Children Over 3 Surveillance Seasons

A. Monto, J. Petrie, S. Ohmit, 2014, The Journal of infectious diseases.

Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains

A. Monto, S. Hensley, J. Petrie, 2016, The Journal of infectious diseases.

Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities

A. Monto, Qingxia Chen, John V. Williams, 2011, PloS one.

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine

A. Monto, B. Flannery, E. Belongia, 2016, Pediatrics.

Respiratory syncytial virus hospitalization in middle-aged and older adults.

A. Monto, B. Flannery, A. Callear, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021

M. Eisenberg, A. Lauring, J. Petrie, 2022, medRxiv.

Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014–2015 and 2015–2016

A. Monto, A. Lauring, J. Petrie, 2018, Epidemiology and Infection.

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons

A. Monto, B. Flannery, E. Belongia, 2018, JAMA network open.

Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing

A. Lauring, J. Petrie, E. Stoneman, 2021, American Journal of Transplantation.

Influenza Vaccine Effectiveness in the Inpatient Setting; Evaluation of Potential Bias in the Test Negative Design by use of Alternate Control Groups.

A. Monto, Caroline K. Cheng, A. Lauring, 2020, American journal of epidemiology.

Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

A. Monto, B. Flannery, M. Nowalk, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population

M. Eichelberger, A. Monto, Caroline K. Cheng, 2018, bioRxiv.

Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness.

A. Monto, Yuwei Zhu, J. Petrie, 2019, Vaccine.

Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season

A. Monto, A. Lauring, J. Petrie, 2018, bioRxiv.

Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

A. Monto, A. Arroliga, H. Eng, 2020, The Journal of infectious diseases.

The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade.

A. Monto, S. Hensley, J. Petrie, 2022, Journal of virology.

Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines

A. Gordon, J. Petrie, 2018, Vaccines.

Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.

A. Monto, J. Petrie, S. Ohmit, 2011, The Journal of infectious diseases.

Practice of Epidemiology Inﬂuenza Vaccine Effectiveness in the Inpatient Setting: Evaluation of Potential Bias in the Test-Negative Design by Use of Alternate Control Groups

A. Monto, Caroline K. Cheng, A. Lauring, 2020 .

Rethinking the “Pan-Culture”: Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia

K. Kaye, L. Saravolatz, J. Petrie, 2022, Open forum infectious diseases.

Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season.

A. Monto, H. Eng, B. Flannery, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

A. Monto, B. Flannery, E. Belongia, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.

A. Monto, B. Flannery, E. Belongia, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study

A. Monto, B. Flannery, A. Gordon, 2019, International journal of epidemiology.

Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.

Manish M Patel, J. D. da Silva, A. Monto, 2020, The Journal of infectious diseases.

Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.

A. Monto, J. Petrie, 2017, The Journal of infectious diseases.

SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.

M. Tewari, A. Lauring, J. Petrie, 2021, The Journal of infectious diseases.

Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients

M. Tewari, A. Lauring, J. Petrie, 2021, The Journal of Infectious Diseases.

SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients

M. Tewari, A. Lauring, J. Petrie, 2021, medRxiv.

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

A. Monto, C. Rinaldo, E. Belongia, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prior season vaccination and risk of influenza during the2014–2015 season in the U.S

A. Monto, B. Flannery, E. Belongia, 2017 .

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States.

A. Monto, B. Flannery, E. Belongia, 2017, The Journal of infectious diseases.

Influenza B Viruses Exhibit Lower Within-Host Diversity than Influenza A Viruses in Human Hosts

A. Monto, A. Lauring, J. Petrie, 2019, Journal of Virology.

Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses

A. Monto, A. Lauring, J. Petrie, 2016, bioRxiv.

Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts

A. Lauring, J. Petrie, E. Martin, 2021, PLoS pathogens.

Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study

A. Monto, A. Callear, J. Petrie, 2020, medRxiv.

Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts

A. Lauring, J. Petrie, E. Martin, 2021, bioRxiv.

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015

Richard K. Zimmerman, Alicia M. Fry, Michael L. Jackson, 2015, MMWR. Morbidity and mortality weekly report.

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013

S. Wisniewski, A. Monto, N. Cox, 2013, MMWR. Morbidity and mortality weekly report.

Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning.

J. Zelner, A. Monto, J. Petrie, 2019, The Journal of infectious diseases.

The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade

A. Monto, S. Hensley, J. Petrie, 2022, bioRxiv.

Improving influenza vaccine effectiveness: ways to begin solving the problem.

A. Monto, J. Petrie, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014–2015 Influenza Vaccine

M. Eichelberger, A. Monto, L. Gubareva, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza vaccine effectiveness in the community and the household.

B. Cowling, A. Monto, D. Shay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Investigating Epidemiologic and Molecular Links Between Patients With Community- and Hospital-Acquired Influenza A: 2017–2018 and 2019–2020, Michigan

K. Kaye, A. Lauring, J. Petrie, 2023, Open forum infectious diseases.

SARS-CoV-2 Genomic Surveillance Reveals Little Spread From a Large University Campus to the Surrounding Community

D. O’Connor, T. Friedrich, R. Woods, 2021, Open forum infectious diseases.

SARS-CoV-2 Genomic Surveillance Reveals Little Spread Between a Large University Campus and the Surrounding Community

R. Woods, A. Lauring, J. Petrie, 2021, medRxiv.

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.

A. Monto, E. Belongia, J. Treanor, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Doctrine of Original Antigenic Sin: Separating Good From Evil

A. Monto, J. Petrie, E. Martin, 2017, The Journal of infectious diseases.

Multimorbidity is associated with uptake of influenza vaccination.

J. Petrie, L. Lamerato, M. Wei, 2018, Vaccine.

Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011–2012 and 2012–2013: The Importance of Two Priming Doses

A. Monto, B. Flannery, E. Belongia, 2016, The Pediatric infectious disease journal.

Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022

G. Neumann, Y. Kawaoka, E. Belongia, 2023, Influenza and other respiratory viruses.

Comparative efficacy of inactivated and live attenuated influenza vaccines.

A. Monto, J. Petrie, S. Ohmit, 2009, The New England journal of medicine.

Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.

A. Monto, J. Katz, J. Petrie, 2015, The Journal of infectious diseases.

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023

G. Neumann, Y. Kawaoka, E. Belongia, 2023, MMWR. Morbidity and mortality weekly report.

Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015.

A. Monto, B. Flannery, Caroline K. Cheng, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015.

A. Monto, B. Flannery, Caroline K. Cheng, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type

Richard K. Zimmerman, Alicia M. Fry, Michael L. Jackson, 2014, The Journal of infectious diseases.

K‐medoids clustering of hospital admission characteristics to classify severity of influenza virus infection

A. Monto, B. Flannery, Caroline K. Cheng, 2023, Influenza and other respiratory viruses.

Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community

K. Ainslie, A. Monto, M. Haber, 2018, Statistics in medicine.

Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort

A. Monto, M. Eisenberg, J. Petrie, 2017, American journal of epidemiology.

Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

A. Monto, J. Petrie, S. Ohmit, 2015, The Journal of infectious diseases.

Factors associated with influenza vaccine receipt in community dwelling adults and their children.

A. Monto, A. Aiello, J. Petrie, 2014, Vaccine.

Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013

S. Wisniewski, A. Monto, N. Cox, 2013, MMWR. Morbidity and mortality weekly report.

Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013.

A. Monto, B. Flannery, Caroline K. Cheng, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.

A. Monto, A. Lauring, J. Petrie, 2019, The Journal of infectious diseases.

Health Care–Acquired Viral Respiratory Diseases

T. Talbot, J. Petrie, 2021, Infectious disease clinics of North America.

Respiratory virus circulation during the first year of the COVID‐19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort

A. Monto, A. McDermott, J. Petrie, 2022, medRxiv.

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

A. Monto, B. Flannery, E. Belongia, 2016, The Journal of infectious diseases.

Vaccine Induced Protection Against Influenza: Persistence of Serum Antibodies, Vaccine Efficacy as a Function of Time, and Use of Transmission Models to Estimate Vaccine Effectiveness in Household Cohort Studies.

J. Petrie, 2016 .

Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan

A. Monto, A. Callear, J. Petrie, 2020, The Journal of infectious diseases.

Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures.

A. Monto, J. Petrie, S. Ohmit, 2011, The Journal of infectious diseases.

Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo

F. Bushman, J. Bloom, A. Monto, 2018, Journal of Virology.

Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses

A. Monto, D. Esposito, D. Follmann, 2021, The Journal of Infectious Diseases.

Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators

Manish M Patel, A. Monto, A. Arroliga, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?

A. Monto, A. Callear, J. Petrie, 2021, medRxiv.

Influenza vaccine effectiveness against drifted versus vaccine-like A/H3N2 viruses during the 2014-15 influenza season—US Flu VE Network

A. Monto, R. Garten, L. Gubareva, 2015 .

Agreement between state registry, health record, and self-report of influenza vaccination.

A. Monto, J. Petrie, E. Martin, 2021, medRxiv.

HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

Lindsay N. Carpp, A. Monto, Y. Fong, 2019, BMC Infectious Diseases.

Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study

B. Flannery, M. Nowalk, J. Petrie, 2021, BMC Public Health.

Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated.

A. Monto, J. Petrie, S. Ohmit, 2016, The Journal of infectious diseases.

Influenza Transmission in a Cohort of Households with Children: 2010-2011

B. Cowling, A. Monto, J. Petrie, 2013, PloS one.

Improving antibiotic use for sinusitis and upper respiratory tract infections: A virtual-visit antibiotic stewardship initiative

K. Kaye, J. Petrie, J. Nagel, 2022, Infection Control & Hospital Epidemiology.

A. Monto, D. Esposito, D. Follmann, 2021, The Journal of infectious diseases.

Comparing the Etiology of Viral Acute Respiratory Illnesses Between Children Who Do and Do Not Attend Childcare

A. Monto, J. Petrie, E. Martin, 2023, The Pediatric Infectious Disease Journal.

Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan

A. Monto, A. Callear, J. Petrie, 2021, Influenza and other respiratory viruses.

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

A. Monto, B. Flannery, E. Belongia, 2016, The Journal of infectious diseases.

Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014–2015

A. Monto, B. Flannery, A. Lauring, 2015, Open Forum Infectious Diseases.

Hospital Associated Respiratory Virus Infection in Children and Adults: It Does Not Just Occur During Cold and Flu Season

K. Kaye, A. Lauring, J. Petrie, 2020, Open forum infectious diseases.

Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

D. Pakstis, A. Monto, Xiyan Xu, 2018, The Journal of infectious diseases.

Influenza A(H7N9) Virus Evolution: Which Genetic Mutations Are Antigenically Important?

A. Lauring, J. Petrie, 2018, Journal of Infectious Diseases.

Immune response to COVID-19 vaccination in a population with a history of elevated exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water

D. Savitz, J. Petrie, E. Martin, 2023, Journal of Exposure Science & Environmental Epidemiology.

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013

S. Wisniewski, A. Monto, N. Cox, 2013, MMWR. Morbidity and mortality weekly report.

Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014–2015 and 2015–2016

A. Monto, A. Lauring, J. Petrie, 2018, Epidemiology and Infection.

Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

A. Monto, B. Flannery, M. Nowalk, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of RSV-A and RSV-B in Adults and Children with Medically-Attended Acute Respiratory Illness over Three Seasons

A. Monto, J. Petrie, E. Martin, 2022, medRxiv.

Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013

S. Wisniewski, A. Monto, N. Cox, 2013, MMWR. Morbidity and mortality weekly report.

Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults

A. Monto, Xiyan Xu, A. Arroliga, 2020, medRxiv.

Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.

A. Monto, J. Petrie, 2017, The Journal of infectious diseases.